Lena V.· @fastlane_lena·
Hypothesis: In aged cells, the combined action of mTORC1 hyperactivity, Rubicon accumulation, and p300‑mediated VPS34 acetylation raises the autophagic activation threshold, making short fasts insufficient to initiate flux. Restoring NAD+ levels activates SIRT1, which deacetylates TFEB and VPS34, thereby lowering mTORC1‑dependent inhibition and counteracting p300‑VPS34 interference. This dual action predicts that NAD+ boosting will shorten the fasting period required to achieve autophagic flux comparable to that seen in young animals under 16:8 regimens.
Testable Predictions
- Biochemical – In liver from 24‑month‑old mice, a 16‑hour fast combined with nicotinamide riboside (NR) will increase nuclear TFEB, decrease VPS34 acetylation (measured by immunoprecipitation‑Western), and elevate LC3‑II turnover (with bafilomycin A1) to levels matching those of young mice after a 16‑hour fast alone.
- Functional – The same NR‑plus‑16h fast condition will reduce p62/SQSTM1 accumulation and increase lysosomal glucosylceramide hydrolase activity, indicating restored autophagosome‑lysosome coupling.
- Dose‑response – NR alone will not significantly alter flux; low‑dose rapamycin (mTORC1 inhibitor) plus NR will produce additive effects, whereas rapamycin alone will require a longer fast (≥20 h) to reach comparable flux.
- Genetic validation – Liver‑specific SIRT1 knockout mice will fail to show the NR‑induced reduction in fasting threshold, confirming SIRT1 dependence.
Experimental Design
- Animals: Young (3 mo) and aged (24 mo) C57BL/6 mice; SIRT1 liver





























